Creative Medical Technology Holdings Announces Reversion of Liver Failure Using ImmCelz� Personalized Cellular Immunotherapy in Preclinical Model
gurufocus,
Company Files Patent on Approaching 10 Billion Dollar Liver Disease Market Using "Reprogrammed" Immune Cells PHOENIX, Dec.